Solid Tumors Targeted in New CAR T-Cell Immunotherapy Trial

Solid Tumors account for 30% of all childhood cancers.  Sarcoma, a cancer that develops in the bone and soft tissue are the most common types of non-central nervous systems solid tumors diagnosed in children. While advances have been made in survival rates over the past several decades, these solid tumors remain among the most resistant…

More »

Very good news for young cancer patients

The Seattle Times recently ran an article in which they featured a “promising Seattle Children’s clinical trial”. You guessed right, they are talking about our very own Dr. Jensen and the amazing success he is having. Please be sure to read the full article so you can get a glimpse into where Make Some Noise…

More »

Strong Against Cancer!

Russell Wilson with children, Strong for Cancer

What do Seahawks QB Russell Wilson, Seattle Children’s Hospital Research Foundation, and Make Some Noise: Cure Kids Cancer have in common? We are all STRONG AGAINST CANCER!  Seattle Children’s has launched a multi-year $100 Million fundraising campaign to support research that scientists believe has the ability to cure some types of childhood cancer within the…

More »

Seattle Children’s begins immunotherapy research trial for Neuroblastoma

Based upon the previous success with immunotherapy for patients with recurring leukemia, Seattle Children’s Research Institute announced the opening of patient enrollment for its new FDA authorized clinical trial designed to induce remission in children suffering from Neuroblastoma, one of the deadliest forms of childhood cancer. The Phase 1 trial is one of the first…

More »

$105,000 presented to Children’s Hospital

Research grant check presentation

Dr. Jensen, the Director of the Ben Towne Center for Childhood Cancer Research at Seattle Children’s Hospital, received a grant check for $105,000.00 from Jack Sutherland, President and CEO of Make Some Noise- Northwest and Junior Board members Maxsena Butler, Tally Black Brown, and Ben LaRoche. The grant consisted of funds realized from “The Cure…

More »

Grand Old Fourth on Bainbridge Island

The Bainbridge High School Cheer Team carried our banner and marched in the Grand Old 4th Parade in Winslow for Make Some Noise – Northwest. The BHS Cheer squads also staffed the Make Some Noise booth, where they painted faces, young and old, in return for donations to kids cancer research at Seattle Children’s Hospital….

More »

‘Cure is Now’ raises $75,000

Art auctioned at The Cure is Now

Over 100 patrons were greeted with a variety of Bainbridge Island Youth artistic talents at “The Cure is Now 2014”, a cocktail reception and auction at the Bainbridge Island Museum of Art, hosted by the Make Some Noise: Cure Kids Cancer – Northwest Junior Board to benefit research for childhood cancer at the Seattle Children’s…

More »

FDA approves second pediatric leukemia T cell therapy

Dr. Michael Jensen of Seattle Children’s has announced the FDA approval of the second pediatric leukemia T cell therapy, allowing patients between the ages of 12 months and 27 who have relapsed after bone marrow transplantation. This allows for treatment on an accelerated basis with the latest version of reprogrammed T cells. For many children,…

More »

Another T cell immunotherapy success

Another miraculous T cell immunotherapy success is reported. Seattle Children’s Hospital Research Institute announced on February 18 that patient Milton Wright III, diagnosed for the third time with leukemia and given little chance of survival, was infused with his own reprogrammed T cells and within two weeks was leukemia free. This is the second encouraging…

More »

Juno biotech launch focuses on immunotherapies for cancer

The Fred Hutchinson Cancer Research Center (Fred Hutch) and Memorial Sloan-Kettering Cancer Center (MSKCC), along with pediatric partner Seattle Children’s Research Institute, have joined forces to launch Juno Therapeutics Inc., a new biotechnology company focused on bringing forward novel immunotherapies for cancer. Juno is being launched with an initial investment of $120M, making it one…

More »